Qing Yi Selected Research

Poly(amidoamine)

1/2022

Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing Yi Research Topics

Disease

74	Neoplasms (Cancer) 01/2024 - 05/2002
43	Multiple Myeloma 01/2024 - 05/2002
10	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2013 - 06/2007
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 06/2012
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
3	Carcinogenesis 01/2021 - 05/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 06/2011
2	Infections 02/2022 - 01/2011
2	Adenocarcinoma of Lung 01/2022 - 10/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2010
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2007
2	Monoclonal Gammopathy of Undetermined Significance 01/2019 - 10/2018
2	Neoplasm Metastasis (Metastasis) 10/2018 - 01/2015
2	Bone Resorption 08/2017 - 01/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 08/2017 - 12/2003
2	Lymphoma (Lymphomas) 09/2013 - 02/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2003 - 04/2002
1	Fibrosis (Cirrhosis) 12/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2023
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	T-Cell Leukemia (Leukemia, T Cell) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Obesity 01/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2002
13	AntigensIBA 01/2024 - 05/2002
12	VaccinesIBA 01/2018 - 12/2005
8	Bortezomib (Velcade)FDA Link 01/2022 - 06/2009
6	Monoclonal AntibodiesIBA 01/2024 - 10/2006
5	Chimeric Antigen ReceptorsIBA 01/2024 - 03/2014
5	CytokinesIBA 01/2021 - 06/2011
5	LigandsIBA 01/2018 - 01/2011
5	Interleukin-6 (Interleukin 6)IBA 01/2015 - 12/2006
4	Peptides (Polypeptides)IBA 01/2024 - 09/2011
4	Interleukin-9 (Interleukin 9)IBA 01/2022 - 11/2012
4	p38 Mitogen-Activated Protein KinasesIBA 12/2017 - 03/2006
4	AntibodiesIBA 08/2017 - 04/2008
4	Lenalidomide (CC 5013)FDA Link 11/2015 - 09/2009
3	HLA-A*02:01 antigenIBA 01/2024 - 09/2011
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2016
3	Interleukin-33IBA 01/2019 - 01/2018
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2014 - 12/2005
3	Cyclin D1IBA 06/2012 - 02/2008
3	azaspiraneIBA 03/2012 - 06/2007
3	Neoplasm Antigens (Tumor Antigens)IBA 10/2009 - 12/2003
2	Caspase 9IBA 01/2024 - 04/2010
2	EpitopesIBA 01/2023 - 09/2011
2	carfilzomibIBA 01/2022 - 11/2013
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 02/2008
2	Proteasome InhibitorsIBA 01/2022 - 03/2012
2	InterferonsIBA 12/2021 - 05/2014
2	CholesterolIBA 01/2021 - 01/2019
2	LipidsIBA 01/2020 - 04/2010
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2019 - 09/2015
2	Immunoglobulin G (IgG)IBA 01/2019 - 07/2011
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	Conditioned Culture MediaIBA 01/2018 - 10/2014
2	Phosphotransferases (Kinase)IBA 12/2017 - 04/2010
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2016 - 09/2011
2	ChemokinesIBA 09/2015 - 06/2011
2	CateninsIBA 10/2014 - 06/2012
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2012 - 04/2010
2	Insulin-Like PeptidesIBA 06/2012 - 04/2010
2	Interleukin-4 (Interleukin 4)IBA 09/2010 - 05/2007
2	Rituximab (Mabthera)FDA Link 09/2009 - 02/2008
1	B-Cell Maturation AntigenIBA 01/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	hederageninIBA 12/2023
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 12/2023
1	InflammasomesIBA 12/2023
1	Cathepsin BIBA 12/2023
1	NigericinIBA 12/2023
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 10/2022
1	Immunoglobulins (Immunoglobulin)IBA 02/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Poly(amidoamine)IBA 01/2022
1	FumaratesIBA 01/2022
1	Acetate-CoA Ligase (Acetyl CoA Synthetase)IBA 01/2021
1	Cruciform DNA (Holliday Junctions)IBA 01/2021
1	Granzymes (Granzyme)IBA 11/2020
1	UbiquitinIBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	daratumumabIBA 01/2020

Therapy/Procedure

35	Immunotherapy 01/2024 - 05/2002
21	Therapeutics 02/2022 - 12/2003
7	Drug Therapy (Chemotherapy) 01/2022 - 06/2007
2	Immunomodulation 11/2009 - 06/2003
2	Lasers (Laser) 08/2003 - 04/2002
2	Light Coagulation 08/2003 - 04/2002
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2021
1	Biological Therapy 11/2020